Relationship between structure and inhibitory effect of arginine analogues on neuronal nitric oxide synthase activity

• Published in: Neurochemical research Vol. 21; no. 10; pp. 1187 - 1192
• Main Authors: YOKOI, I, NAMBA, Y, KABUTO, H, INADA, K, IIDA, M, MORI, A, OGAWA, N
• Format: Journal Article
• Language: English
• Published: New York, NY Springer 01-10-1996
• Subjects: Animals; Arginine - analogs & derivatives; Arginine - chemistry; Arginine - pharmacology; Biochemistry and metabolism; Biological and medical sciences; Central nervous system; Fundamental and applied biological sciences. Psychology; Male; Molecular Structure; Neurons - drug effects; Neurons - enzymology; Nitric Oxide Synthase - antagonists & inhibitors; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Vertebrates: nervous system and sense organs; Rat; Enzyme; Rodentia; Central nervous system; Enzyme inhibitor; Nitric-oxide synthase; Vertebrata; Mammalia; Enzymatic activity; Arginine; Structure activity relation; Analog; Oxidoreductases; Brain (vertebrata)
• ISSN: 0364-3190; 1573-6903
• DOI: 10.1007/BF02532394

Since nitric oxide (NO) is synthesized by nitric oxide synthase (NOS) from L-arginine (Arg) which has an amidino group in its molecule, we examined the effect of 29 kinds of Arg analogues on neuronal NOS (nNOS) activity in the rat brain. None of the Arg analogues acted as a substrate for nNOS. Diamidinocystamine, hirudonine, and guanethidine inhibited nNOS activity to 67.3%, 64.2% and 74.1%, respectively, but their inhibitory efficiency was lower than NG-monomethyl-L-arginine (to 36.5%) which is a well known NOS inhibitor. Dimethylguanidine and N-benzoylguanidine also significantly inhibited nNOS activity to 88.0% and 90.7%, respectively. Whereas almost all of the NOS inhibitors previously reported were synthesized by substituting the amidino nitrogen of Arg, none of these new inhibitors were substituted at this position. Furthermore, hirudonine, which is a naturally occurring compound, was thought to act as an agonist at polyamine binding site of the N-methyl-D-aspartate type of glutamate receptor complex. It is also interesting that guanethidine, an antihypertensive agent, inhibit nNOS activity. These new drugs are useful for the investigation not only of the chemical nature of nNOS but also of the physiologic function of NO.